Jeffrey Ross, DPM
Podiatrist · Houston, TXNPI 1659395069
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (40.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Lifenet Health at 32.8% of the total. Among podiatrist clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $287.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lifenet Health$5K
- Wound Management Technologies, Inc$3K
- Smith+Nephew$3K
- KCI USA, Inc.$3K
- Medtronic$302
- Baxter Healthcare$184
- plus $1K from 10 others
What the payments were for
- Consulting fees$4,77530%
- Speaking & faculty fees$6,49740%
- Travel & lodging$1,72011%
- Food & beverage$2,82018%
- Education$2902%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lifenet Health | 7 | $5,274 |
| Wound Management Technologies, Inc | 5 | $3,297 |
| Smith+Nephew | 15 | $3,243 |
| KCI USA, Inc. | 5 | $2,655 |
| Medtronic(2 entities) | 3 | $302 |
| Baxter Healthcare | 5 | $184 |
| AbbVie | 3 | $161 |
| Integra Lifesciences Corporation | 3 | $138 |
| Trilliant Surgical LLC. | 1 | $132 |
| Cardiva Medical, Inc. | 1 | $122 |
| Medline Industries LP | 3 | $120 |
| Kerecis Limited | 1 | $119 |
| Abbott | 1 | $117 |
| Stryker | 1 | $98 |
| Averitas Pharma Inc. | 1 | $82 |
| TEI Medical Inc. | 1 | $58 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TheraGenesis Wound Matrix$5,184
- CellerateRx$3,276
- Versajet$2,523
- SNAP$2,194
- VAC VERAFLO$366
- ENDURANT IIS$266
- Stravix$253
- MIB$132
- Cellerate$132
- STRAVIX PL$131
- GRAFIX PL$131
- DALVANCE$125
- CARDIVA VASCADE MVP XL VVCS 10-12F$122
- Kerecis Omega3 Wound$119
- Diamondback Peripheral$117
- VERSAJET II$107
How this compares
$16,101 in reported general payments places this provider in the 90th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 48 | $430 |
| Clindamycin Hcl | 12 | $121 |
| Cefadroxil | 14 | $103 |
| Tramadol Hcl | 22 | $86 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Houston
- Gary LepowHouston$1M
- Andrew SchneiderHouston$150K
- Randall BeckmanHouston$103K
- Jason ArmstrongHouston$91K
- Jerry MilesHouston$58K
- Tina OliverHouston$42K
- Lawrence MactavishHouston$41K
- Roberto de Los SantosHouston$33K
- Randal LepowHouston$33K
- Ava WashkoHouston$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.